TDACW
Translational Development Acquisition Corp.
—
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
None
$1.45
(0.00%)
Price History
52-Week Range
Sign in to add TDACW to a watchlist or set price alerts.
Fundamentals
| Market Cap | - |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | - |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | - |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $1.85 |
| 52-Week Low | $1.85 |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | - |
| Volume | 5.5K |
Performance Analysis
NEUTRALTDACW presents a mixed picture with both positive and negative indicators.
~
Trading at 50% of its 52-week range.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Aug 13, 2026 18:48 UTC
Back to Screener Export Report